Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 11.42 USD -1.38% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Amicus Therapeutics Inc?
Write Note

Amicus Therapeutics Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Net Income
-$119.5m
CAGR 3-Years
22%
CAGR 5-Years
23%
CAGR 10-Years
-8%
Abbvie Inc
NYSE:ABBV
Net Income
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
-$384m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Amicus Therapeutics Inc's Net Income?
Net Income
-119.5m USD

Based on the financial report for Jun 30, 2024, Amicus Therapeutics Inc's Net Income amounts to -119.5m USD.

What is Amicus Therapeutics Inc's Net Income growth rate?
Net Income CAGR 10Y
-8%

Over the last year, the Net Income growth was 35%. The average annual Net Income growth rates for Amicus Therapeutics Inc have been 22% over the past three years , 23% over the past five years , and -8% over the past ten years .

Back to Top